NFKB1 and gestational diabetes: In addition, the naringenin treatment normalized phorspho-JNK and phorspho-NF-κB p65 levels of GDM mice to these of wild-type mice, indicating naringenin efficiently prevented the activation of NF-κB and MAPK signaling pathway.